Diabetes

Basal insulin analogues similar for glucose lowering

(HealthDay)—Basal insulin analogues for type 2 diabetes mellitus (T2DM) do not substantially differ in their glucose-lowering effect, according to a review published online July 10 in the Annals of Internal Medicine.

Diabetes

Bidirectional association for depression, dysglycemia in T1DM

(HealthDay)—For patients with type 1 diabetes (T1D), there is a bidirectional association between depression and severe hypoglycemia and hyperglycemia, according to a study published online Dec. 18 in Diabetes Care.

Diabetes

Dasiglucagon well tolerated for severe hypoglycemia

(HealthDay)—Dasiglucagon is well tolerated and is associated with an early pharmacodynamic response similar to that of GlucaGen for severe hypoglycemia, according to a study published online Dec. 22 in Diabetes Care.

Diabetes

Continuous glucose monitors warn of low blood sugar threat

Continuous glucose monitors (CGM) can protect individuals who have had type 1 diabetes for years and are at risk of experiencing dangerously low blood sugar by increasing their awareness of the symptoms, according to a study ...

page 2 from 5